肿瘤与血池标准化摄取值比及代谢参数预测临床N0肺腺癌隐匿性淋巴结转移
31例(19.7%)检出隐匿性淋巴结转移。多因素分析显示TLGsur(OR 1.024,P=0.002)是预测隐匿性淋巴结转移最强的相关因素,其预测效能优于其他PET参数。
要点
- 临床N0肺腺癌中隐匿性淋巴结转移发生率为19.7%(31/157)。
- TLGsur的OR为1.024(P=0.002),是预测隐匿性淋巴结转移最强的相关因素。
- TLGsur等归一化代谢参数可能有助于选择亚肺叶切除或个体化积极治疗。
核心结论
- TLGsur在预测临床N0肺腺癌隐匿性淋巴结转移方面显示出比其他PET参数更强的预测效能。
- 该归一化体积参数可能有助于选择亚肺叶切除或积极的个体化治疗方案。
研究设计与样本
- 在PET/CT工作站测量原发肿瘤的SUVmax、SUVmean、MTV和总病灶糖酵解(TLG),并以降主动脉SUVmean为分母得出SURmax、SURmean和TLGsur。
- 分析上述PET参数及临床病理变量与隐匿性淋巴结转移的关系。
主要发现
- 157例中31例(19.7%)检出隐匿性淋巴结转移。
- 有隐匿性淋巴结转移的患者肿瘤大小、SUVmax、SUVmean、MTV、TLGsuv、SURmax、SURmean和TLGsur均显著更高。
- 受试者工作特征曲线分析中,上述参数的最佳截断值分别为29.50、4.38、2.45、6.37、44.13、5.30、1.86和28.24。
- 多因素分析显示TLGsur(比值比1.024;P=0.002)是预测临床N0肺腺癌隐匿性淋巴结转移最强的相关因素。
关键数值与推荐
- 隐匿性淋巴结转移检出率为19.7%(31/157)。
- 多因素分析TLGsur的比值比为1.024(P=0.002)。
- 受试者工作特征曲线最佳截断值:肿瘤大小29.50、SUVmax 4.38、SUVmean 2.45、MTV 6.37、TLGsuv 44.13、SURmax 5.30、SURmean 1.86、TLGsur 28.24。
临床怎么用
- 原文结论认为TLGsur可能有助于选择亚肺叶切除或积极的个体化治疗方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to investigate whether the tumor-to-blood SUV ratio (SUR) and metabolic parameters of F-FDG uptake could predict occult lymph node metastasis (OLM) in clinically node-negative (cN0) lung adenocarcinoma. MATERIALS AND METHODS: We retrospectively reviewed 157 patients with cN0 lung adenocarcinoma who underwent both preoperative F-FDG PET/CT and surgical resection with the systematic lymph node dissection. The SUVmax, SUVmean, MTV, and total lesion glycolysis (TLG) of the primary tumor was measured on the PET/CT workstation. SURmax, SURmean, and TLGsur were derived from each of them divided by descending aorta SUVmean. These PET parameters and clinicopathological variables were analyzed for OLM. RESULTS: In our study, OLM was detected in 31 (19.7%) of 157 patients. Significantly higher values of tumor size, SUVmax, SUVmean, MTV, TLGsuv, SURmax, SURmean, and TLGsur were found in patients with OLM. In receiver operating characteristic curve analysis, the optimal cutoff values of the above parameters were 29.50, 4.38, 2.45, 6.37, 44.13, 5.30, 1.86, and 28.24, respectively. The multivariate analysis showed that TLGsur (odds ratio, 1.024; P = 0.002) was the most potent associated factor for the prediction of OLM in cN0 lung adenocarcinoma. CONCLUSIONS: TLGsur showed the most powerful predictive performance than the other PET parameters for the prediction of OLM in cN0 lung adenocarcinoma. This normalized volumetric parameter would be helpful in selection of sublobar resection or aggressive tailored treatments in patients with cN0 lung adenocarcinoma.
引用
- Ouyang ML, Tang K, Xu MM, et al. Prediction of Occult Lymph Node Metastasis Using Tumor-to-Blood Standardized Uptake Ratio and Metabolic Parameters in Clinical N0 Lung Adenocarcinoma. Clin Nucl Med. 2018. PMID: 30106864. doi:10.1097/RLU.0000000000002229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。